ES8605975A1 - Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas - Google Patents

Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Info

Publication number
ES8605975A1
ES8605975A1 ES539500A ES539500A ES8605975A1 ES 8605975 A1 ES8605975 A1 ES 8605975A1 ES 539500 A ES539500 A ES 539500A ES 539500 A ES539500 A ES 539500A ES 8605975 A1 ES8605975 A1 ES 8605975A1
Authority
ES
Spain
Prior art keywords
controlled release
liquid dosage
pharmaceuticals
approximately
dosage formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539500A
Other languages
English (en)
Other versions
ES539500A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Development Corp
Original Assignee
Battelle Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Development Corp filed Critical Battelle Development Corp
Publication of ES8605975A1 publication Critical patent/ES8605975A1/es
Publication of ES539500A0 publication Critical patent/ES539500A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

METODO DE PREPARACION DE FORMULACIONES LIQUIDAS FARMACEUTICAS DE FORMAS DE DOSIFICACION DE LIBERACION CONTROLADA DOBLEMENTE REVESTIDAS. COMPRENDE EL REVESTIMIENTO DE FORMAS DE DOSIFICACION DE LIBERACION CONTROLADA, QUE TIENEN UN COMPUESTO ACTIVO TERAPEUTICAMENTE, CON UNA GRASA O CERA HIDROFOBA, DIGERIBLE, CUYO PUNTO DE FUSION NO ES SUPERIOR A 49JC, PARA FORMAR UN PRIMER REVESTIMIENTO QUE CONSTITUYE MENOS DEL 20% DEL PESO TOTAL; SOBRE-REVESTIMIENTO CON UNA SEGUNDA CAPA, CONSTITUIDA POR UN DERIVADO DE PROLAMINA O CELULOSA, CAPAZ DE HACERSE PERMEABLE A LA PRIMERA HORA DE ENTRAR EN EL TRACTO GASTROINTESTINAL Y QUE CONSTITUYE MENOS DEL 5% DEL PESO TOTAL; Y DISPERSAR LAS FORMAS ASI REVESTIDAS EN UN LIQUIDO ADECUADO, QUE TIENE UN PH INFERIOR A 7. TIENEN APLICACIONES PARA LA PREPARACION DE TABLETAS, CAPSULAS, MICROCAPSULAS Y PERLAS DE MATRIZ DE LIBERACION CONTROLADA.
ES539500A 1984-01-13 1985-01-11 Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas Expired ES8605975A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13

Publications (2)

Publication Number Publication Date
ES8605975A1 true ES8605975A1 (es) 1986-04-01
ES539500A0 ES539500A0 (es) 1986-04-01

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539500A Expired ES8605975A1 (es) 1984-01-13 1985-01-11 Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Country Status (11)

Country Link
EP (1) EP0169236A1 (es)
JP (1) JPS61500910A (es)
AU (1) AU3835885A (es)
CA (1) CA1239347A (es)
ES (1) ES8605975A1 (es)
GR (1) GR850069B (es)
IL (1) IL74049A0 (es)
IT (1) IT1184309B (es)
NZ (1) NZ210785A (es)
WO (1) WO1985003000A1 (es)
ZA (1) ZA85239B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750369T2 (de) * 1986-03-21 1995-05-24 Eurasiam Lab Arzneimittelzusammensetzungen.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
CA2079509C (en) * 1991-10-01 2002-05-14 Shigeyuki Takada Prolonged release microparticle preparation and production of the same
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
WO2004096175A2 (en) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Taste masked microcapsules and processes for their preparation
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Also Published As

Publication number Publication date
ES539500A0 (es) 1986-04-01
NZ210785A (en) 1987-11-27
CA1239347A (en) 1988-07-19
IL74049A0 (en) 1985-04-30
ZA85239B (en) 1985-08-28
WO1985003000A1 (en) 1985-07-18
AU3835885A (en) 1985-07-30
GR850069B (es) 1985-05-03
JPS61500910A (ja) 1986-05-08
IT8519086A0 (it) 1985-01-11
IT1184309B (it) 1987-10-28
EP0169236A1 (en) 1986-01-29

Similar Documents

Publication Publication Date Title
ES8605975A1 (es) Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas
DK1006935T3 (da) Styret afgivelsessystem med en væske med höj viskositet
AU4709989A (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
TW429153B (en) Aerosol compositions
CA2135925A1 (en) Use of glycerin in moderating transdermal drug delivery
AU1785483A (en) Slow release and fast release tablet formulation comprising two active ingredients
CA2016039A1 (en) Extended release pharmaceutical formulations
AU576563B2 (en) Pyridazine derivatives
AU588968B2 (en) Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
ES8500561A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas dermicas de accion prolongada y continua a base de acidos grasos esenciales
ES8502334A1 (es) "un procedimiento para preparar una composicion que contiene elastasa".
AU2609592A (en) Pharmaceutical composition containing felbinac
CA2069433A1 (en) Antiperspirant
KR870003772A (ko) 2-(2-플루오로-4-비페닐릴)프로피온산을 함유하는 약제학적 조성물의 제조방법
IE810036L (en) Sustained release compositions
EP0208519A3 (en) Solubilized composition of hardly-soluble pharmaceutical product
AU4538489A (en) Pharmaceutical compositions
IE44739L (en) Purine derivatives
CA2067365A1 (en) Illudin analogs as anti-tumor agents
CA2109796A1 (en) Modulation of cellular response to external stimuli
NO962129L (no) Ny farmasöytisk blanding for fremstilling av et stabilt pulver inneholdende et aktivt prinsipp omfattende en forbindelse av acetylsalicylsyre og metoklopramid
CA2128103A1 (en) Formulation and use of carotenoids in treatment of cancer
US5200428A (en) Agent for the tsh suppression and treatment of struma
JPS57134414A (en) Preparation of sugar-coated tablet
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof